
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
α1A-AR CRISPR/Cas9 KO Plasmid (m2) | sc-419021-KO-2 | 20 µg | $397.00 | |||
α1A-AR HDR Plasmid (m2) | sc-419021-HDR-2 | 20 µg | $445.00 |
Adra1a encodes the mouse α1A-adrenergic receptor (α1A-AR), a G protein–coupled receptor that primarily signals through Gq/11 to stimulate phospholipase C, inositol phosphate production, intracellular Ca2+ mobilization, and PKC-dependent phosphorylation cascades. α1A-AR activation also interfaces with MAPK/ERK and RhoA-mediated cytoskeletal remodeling, shaping smooth muscle contractility and neuronal excitability in a tissue- and context-dependent manner. This receptor contributes to sympathetic regulation of vascular tone and lower urinary tract function and is studied in models of cardiovascular physiology, neurobiology, and organ-specific remodeling. Dysregulated adrenergic signaling is commonly leveraged to probe mechanisms underlying hypertension-related vascular responses, stress-associated neural circuitry, and urogenital smooth muscle hyperreactivity in preclinical research.
α1A-AR CRISPR/Cas9 KO Plasmid (m2) is a pool of plasmids designed for targeted disruption of the Adra1a gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Adra1a locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, α1A-AR HDR Plasmid (m2) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Adra1a target site.
When co-transfected with α1A-AR CRISPR/Cas9 KO Plasmid (m2):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Adra1a locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.